Given the current share price, I guess there won't be any shortfall for the 1 for 20 entitlement at 0.105. So no point applying for excess?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025